Table 2.
Serum Sample | Initial (pg/mL) | Added (pg/mL) | Found (pg/mL) | Recovery (%) | |
---|---|---|---|---|---|
Healthy | 1* | – | 1 | 1.04 ± 0.03 | 103.9 |
2* | – | 5 | 4.87 ± 0.22 | 97.4 | |
3* | – | 10 | 10.81 ± 0.69 | 108.1 | |
4* | – | 50 | 49.25 ± 1.72 | 98.4 | |
5# | – | 1 | 1.06 ± 0.06 | 106.3 | |
6# | – | 5 | 5.11 ± 0.18 | 102.3 | |
7# | – | 10 | 10.94 ± 0.55 | 109.4 | |
8# | – | 50 | 52.35 ± 1.26 | 104.7 | |
COVID-19 Patient | 1* | 5.15 ± 0.34 | 10 | 14.47 ± 0.34 | 95.5 |
2* | 1.85 ± 0.12 | 10 | 12.37 ± 0.44 | 104.5 | |
3* | 27.59 ± 1.42 | 10 | 40.07 ± 2.53 | 106.6 | |
4* | 5.28 ± 0.33 | 10 | 16.42 ± 0.46 | 107.5 | |
5# | 37.05 ± 0.96 | 10 | 42.85 ± 1.34 | 91.1 | |
6# | 129.8 ± 4.04 | 10 | 146.5 ± 3.72 | 104.8 |
“-”: undetectable
“*”: 100-fold diluted; “#”: 20-fold diluted